Macrocyclic chelator assembled RGD multimers for tumor targeting
Graphical abstract
Section snippets
Acknowledgments
This work was supported in part by the National Cancer Institute (NCI) grant R01 CA119053 (to Z.C.) and a China Scholarship Council fellowship (to X.Z.).
References and notes (12)
Bioconjugate Chem.
(2009)Mol. Pharm.
(2006)Contrast Media. Mol. Imaging
(2006)et al.J. Pept. Sci.
(2007)et al.Expert Opin. Ther. Targets
(2004)- et al.
Bioconjugate Chem.
(2005)et al.J. Nucl. Med.
(2007)et al.J. Nucl. Med.
(2005)et al.Org. Biomol. Chem.
(2006) - et al.
J. Med. Chem.
(2006)et al.J. Recept. Signal Transduct. Res.
(2007)et al.J. Am. Chem. Soc.
(2004)et al.Nat. Biotechnol.
(1997) - et al.
Org. Biomol. Chem.
(2009)et al.Mol. Cancer Ther.
(2007) - et al.
Plos One.
(2011)et al.Bioconjug. Chem.
(2011) - et al.
Org. Biomol. Chem.
(2007)et al.Mol. Pharm.
(2008)et al.J. Med. Chem.
(2006)
There are more references available in the full text version of this article.
Cited by (9)
The Scope of Application of Macrocyclic Polyamines Beyond Metal Chelation
2019, European Journal of Organic ChemistrySmall peptide and protein-based molecular probes for imaging neurologi-cal diseases
2016, Current Protein and Peptide ScienceStrained cyclooctyne as a molecular platform for construction of multimodal imaging probes
2015, Angewandte Chemie - International EditionChelators for copper radionuclides in positron emission tomography radiopharmaceuticals
2014, Journal of Labelled Compounds and RadiopharmaceuticalsRGD-based PET tracers for imaging receptor integrin α <inf>v</inf>β<inf>3</inf> expression
2013, Journal of Labelled Compounds and Radiopharmaceuticals
Copyright © 2011 Elsevier Ltd. All rights reserved.